FDA Moves to Ban Ineffective Cold Medicine Phenylephrine

The FDA plans to remove oral phenylephrine, a common ingredient in over-the-counter cold medicines, from the market due to its ineffectiveness as a nasal decongestant. This decision follows a review of data showing minimal absorption of the drug when ingested, rendering it no more effective than a placebo. The public can comment on the proposal until May 7, 2025, after which manufacturers may need to reformulate or withdraw affected products. The Consumer Healthcare Products Association opposes the move, arguing for consumer choice.